{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:29:45Z","timestamp":1792002585104,"version":"4.4.0"},"reference-count":55,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2020,2,15]],"date-time":"2020-02-15T00:00:00Z","timestamp":1581724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2018-05610"],"award-info":[{"award-number":["RGPIN-2018-05610"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>An architectural polymer containing hydrophobic isoxazole-based dendron and hydrophilic polyethylene glycol linear tail is prepared by a combination of the robust ZnCl2 catalyzed alkyne-nitrile oxide 1,3-dipolar cycloaddition and esterification chemistry. This water soluble amphiphilic telodendrimer acts as a macromolecular biologically active agent and shows concentration dependent reduction of glioblastoma (U251) cell survival.<\/jats:p>","DOI":"10.3390\/molecules25040857","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T05:44:12Z","timestamp":1582695852000},"page":"857","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Telodendrimer-Based Macromolecular Drug Design using 1,3-Dipolar Cycloaddition for Applications in Biology"],"prefix":"10.3390","volume":"25","author":[{"given":"Hossein","family":"Yazdani","sequence":"first","affiliation":[{"name":"Department of Chemistry, McGill University, 801 Sherbrooke St. West, Montr\u00e9al, QC H3A 0B8, Canada"},{"name":"Department of Chemistry, Shahid Beheshti University G.C., Tehran 1983963113, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esha","family":"Kaul","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, McGill University, 3655 Promenade Sir William Osler, Montr\u00e9al, QC H3G 1Y6, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayoob","family":"Bazgir","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Shahid Beheshti University G.C., Tehran 1983963113, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0017-5201","authenticated-orcid":false,"given":"Dusica","family":"Maysinger","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, McGill University, 3655 Promenade Sir William Osler, Montr\u00e9al, QC H3G 1Y6, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Kakkar","sequence":"additional","affiliation":[{"name":"Department of Chemistry, McGill University, 801 Sherbrooke St. West, Montr\u00e9al, QC H3A 0B8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,2,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1186\/bcr1996","article-title":"NVP-AUY922: A small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models","volume":"10","author":"Jensen","year":"2008","journal-title":"Breast Cancer Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/ewjm.176.1.51","article-title":"Management of uncomplicated urinary tract infections","volume":"176","author":"Jancel","year":"2002","journal-title":"West. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10753-015-0247-5","article-title":"3, 5-disubstituted isoxazole derivatives: Potential inhibitors of inflammation and Cancer","volume":"39","author":"Rakesh","year":"2016","journal-title":"Inflammation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1021\/jm0704806","article-title":"Quantitative Structure\u2212Activity Relationship Studies of [(Biphenyloxy) propyl] isoxazole Derivatives. Inhibitors of Human Rhinovirus 2 Replication","volume":"50","author":"Artemenko","year":"2007","journal-title":"J. Med. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.bmcl.2005.02.039","article-title":"Design, synthesis, biological evaluation and molecular docking of curcumin analogues as antioxidant, cyclooxygenase inhibitory and anti-inflammatory agents","volume":"15","author":"Selvam","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"7449","DOI":"10.1021\/bi400734e","article-title":"Stable and potent analogues derived from the modification of the dicarbonyl moiety of curcumin","volume":"52","author":"Chakraborti","year":"2013","journal-title":"Biochemistry"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1124\/mol.112.080689","article-title":"A novel EPAC-specific inhibitor suppresses pancreatic cancer cell migration and invasion","volume":"83","author":"Almahariq","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1016\/j.bmc.2018.05.013","article-title":"The recent progress of isoxazole in medicinal chemistry","volume":"26","author":"Zhu","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"ref_9","unstructured":"Drysdale, M.J., Dymock, B.W., Finch, H., Webb, P., McDonald, E., James, K.E., Cheung, K.M., and Matthews, T.P. (2017). Isoxazole Compounds as Inhibitors of Heat Shock Proteins. (2017326152 A1), U.S. Patent."},{"key":"ref_10","unstructured":"FU, J., Jin, X., Karur, S., Lapointe, G., Madera, A.M., and Sweeney, Z.K. (2018). Isoxazole Hydroxamic Acid Compounds as LpxC Inhibitors. (20180030004 A1), U.S. Patent."},{"key":"ref_11","unstructured":"Fu, J.P., Jiang, S.Y., Kordikowski, A., and Sweeney, Z.K. (2017). Crystalline Isoxazole Hydroxamic Acid Compounds. (2017355684 A1), U.S. Patent."},{"key":"ref_12","unstructured":"Foley Megan, A.C., Kuntz, K.W., Mills James, E.J., Mitchell, L.H., Munchhof, M.J., and Harvey, D.M. (2017). Isoxazole Carboxamide Compounds. (2017190676 A1), U.S. Patent."},{"key":"ref_13","unstructured":"Duggan, M.E. (2017). Deuterated Isoxazole Derivatives and Their Use as Metabotropic Glutamate Receptor Potentiators. (WO2017089892 A1)."},{"key":"ref_14","unstructured":"Sun, O.Y., Ma, J., Wang, B., He, Y., Xing, X., Shen, R., Granger, B., He, J., Long, J., and Wang, G. (2017). Isoxazole Analogs As FXR Agonists And Methods Of Use Thereof. (2017334893 A1), U.S. Patent."},{"key":"ref_15","unstructured":"Sun, O.Y., He, Y., Shen, R.C., Xing, X., Granger, B., Wang, B., Ma, J., He, J., Long, J., and Wang, G. (2017). Isoxazole Derivatives As FXR Agonists And Methods Of Use Thereof. (2017334894 A1), U.S. Patent."},{"key":"ref_16","unstructured":"Das, A.M., Hazarika, M.P., and Deka, B.P. (2016). Diosgenin Acetate-Isoxazole Derivatives, Process for Preparation Thereof and Their Antifungal Activity. (WO2016135749 A1)."},{"key":"ref_17","unstructured":"Kotoku, M., Maeba, T., Seki, N., Hirashima, S., Fujioka, S., Obika, S., Yamanaka, H., Yokota, M., Sakai, T., and Hirata, K. (2016). Triazole-Isoxazole Compound And Medical USE Thereof. (2016137639 A1), U.S. Patent."},{"key":"ref_18","unstructured":"Cole, B., and Kolodziej, A. (2016). Isoxazole Compounds and Methods for the Treatment of Cystic Fibrosis. (2016128984 A1), U.S. Patent."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Yang, J., and Kopecek, J. (2014). Macromolecular therapeutics. J. Control. Rel., 288\u2013303.","DOI":"10.1016\/j.jconrel.2014.04.013"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1705328","DOI":"10.1002\/adma.201705328","article-title":"Advances in biomaterials for drug delivery","volume":"30","author":"Fenton","year":"2018","journal-title":"Adv. Mater."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jconrel.2019.11.029","article-title":"Stimuli-responsive chitosan as an advantageous platform for efficient delivery of bioactive agents","volume":"317","author":"Sabourian","year":"2020","journal-title":"J. Control. Rel."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1080\/17425247.2018.1529756","article-title":"Amphiphilic block copolymers in drug delivery: Advances in formulation structure and performance","volume":"15","author":"Bodratti","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4155\/tde-2015-0012","article-title":"Nanocarrier fabrication and macromolecule drug delivery: Challenges and opportunities","volume":"7","author":"Agrahari","year":"2016","journal-title":"Ther. Deliv."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41570-017-0063","article-title":"Evolution of macromolecular complexity in drug delivery systems","volume":"1","author":"Kakkar","year":"2017","journal-title":"Nat. Rev. Chem"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1021\/acsabm.9b00643","article-title":"Unraveling aqueous self-assembly of telodendrimers to shed light on their efficacy in drug encapsulation","volume":"2","author":"Moquin","year":"2019","journal-title":"ACS Appl. Bio Mater."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"9766","DOI":"10.1021\/acs.jpcb.6b06070","article-title":"Drug-specific design of telodendrimer architecture for effective doxorubicin encapsulation","volume":"120","author":"Jiang","year":"2016","journal-title":"J. Phys. Chem. B"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.4155\/tde.13.91","article-title":"Telodendrimer-based nanocarriers for the treatment of ovarian cancer","volume":"4","author":"Xiao","year":"2013","journal-title":"Ther. Deliv."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1021\/acs.molpharmaceut.7b00019","article-title":"Telodendrimers for physical encapsulation and covalent linking of individual or combined therapeutics","volume":"14","author":"Choi","year":"2017","journal-title":"Mol. Pharm."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1021\/mp500181x","article-title":"PEG-farnesyl thiosalicylic acid telodendrimer micelles as an improved formulation for targeted delivery of paclitaxel","volume":"11","author":"Zhang","year":"2014","journal-title":"Mol. Pharm."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Padwa, A., and Pearson, W.H. (2003). Synthetic Applications of 1,3-Dipolar Cycloaddition Chemistry Toward Heterocycles and Natural Products, Wiley.","DOI":"10.1002\/0471221902"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5737","DOI":"10.1039\/C7OB01142C","article-title":"Direct access to isoxazolino and isoxazolo benzazepines from 2-((hydroxyimino) methyl) benzoic acid via a post-Ugi heteroannulation","volume":"15","author":"Balalaie","year":"2017","journal-title":"Org. Biomol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Ladd, E., Sheikhi, A., Li, N., van de Ven, T., and Kakkar, A. (2017). Design and synthesis of dendrimers with facile surface group functionalization, and an evaluation of their bactericidal efficacy. Molecules, 22.","DOI":"10.3390\/molecules22060868"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1055\/s-0037-1610676","article-title":"Lewis Acid Catalyzed Regio-and Diastereoselective Synthesis of Spiroisoxazolines via One-Pot Sequential Knoevenagel Condensation\/1,3-Dipolar Cycloaddition Reaction","volume":"51","author":"Yazdani","year":"2019","journal-title":"Synthesis"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1021\/mz5006298","article-title":"Combined A3 coupling and click chemistry approach for the synthesis of dendrimer-based biological tools","volume":"3","author":"Sharma","year":"2014","journal-title":"ACS Macro Lett."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"16987","DOI":"10.3390\/molecules200916987","article-title":"Designing dendrimer and miktoarm polymer based multi-tasking nanocarriers for efficient medical therapy","volume":"20","author":"Sharma","year":"2015","journal-title":"Molecules"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/mabi.201500186","article-title":"Asymmetric AB3 Miktoarm Star Polymers: Synthesis, Self-Assembly, and Study of Micelle Stability Using AF4 for Efficient Drug Delivery","volume":"15","author":"Moquin","year":"2015","journal-title":"Macromol. Biosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"415602","DOI":"10.1088\/0957-4484\/27\/41\/415602","article-title":"Surface engineering of SPIONs: Role of phosphonate ligand multivalency in tailoring their efficacy","volume":"27","author":"Lam","year":"2016","journal-title":"Nanotechnology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6688","DOI":"10.1021\/la050206j","article-title":"New fluorescence method for the determination of the critical micelle concentration by photosensitive monoazacryptand derivative","volume":"21","author":"Nakahara","year":"2005","journal-title":"Langmuir"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1158\/0008-5472.CAN-07-5256","article-title":"NVP-AUY922: A novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis","volume":"68","author":"Eccles","year":"2008","journal-title":"Cancer Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jtho.2017.11.131","article-title":"Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non\u2013Small Cell Lung Cancer","volume":"13","author":"Felip","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ejmech.2010.12.004","article-title":"Synthesis and biological evaluation of 3,5-diaryl isoxazoline\/isoxazole linked 2, 3-dihydroquinazolinone hybrids as anticancer agents","volume":"46","author":"Kamal","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/eji.200940160","article-title":"Pyroptosis\u2013A cell death modality of its kind?","volume":"40","author":"Kepp","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.it.2017.01.003","article-title":"Recent Insights into the Molecular Mechanisms Underlying Pyroptosis and Gasdermin Family Functions","volume":"38","author":"Aglietti","year":"2017","journal-title":"Trends Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.tcb.2017.05.005","article-title":"Gasdermins: Effectors of Pyroptosis","volume":"27","author":"Kovacs","year":"2017","journal-title":"Trends Cell Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev-cancerbio-030518-055844","article-title":"The hallmarks of ferroptosis","volume":"3","author":"Dixon","year":"2019","journal-title":"Ann. Rev. Can. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/imr.12533","article-title":"Ferroptosis: Bug or feature?","volume":"277","author":"Dixon","year":"2017","journal-title":"Immunol. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","article-title":"Ferroptosis: Death by Lipid Peroxidation","volume":"26","author":"Yang","year":"2016","journal-title":"Trends Cell Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tips.2017.02.005","article-title":"Ferroptosis Inhibition: Mechanisms and Opportunities","volume":"38","author":"Angeli","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1704007","DOI":"10.1002\/adma.201704007","article-title":"Emerging Strategies of Cancer Therapy Based on Ferroptosis","volume":"30","author":"Shen","year":"2018","journal-title":"Adv. Mater."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/nbt1339","article-title":"Mechanisms and optimization of in vivo delivery of lipophilic siRNAs","volume":"25","author":"Wolfrum","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3892\/or.2017.5718","article-title":"Cancer drug delivery in the nano era: An overview and perspectives","volume":"38","author":"Li","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Mokhtari","year":"2017","journal-title":"Oncotarget"},{"key":"ref_54","first-page":"131","article-title":"Anticancer and cardio-protective effects of liposomal doxorubicin in the treatment of breast cancer","volume":"10","author":"Franco","year":"2018","journal-title":"Breast Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3389\/fphar.2018.00582","article-title":"Human albumin fragments nanoparticles as PTX carrier for improved anti-cancer efficacy","volume":"9","author":"Ge","year":"2018","journal-title":"Front. Pharmacol."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/4\/857\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:58:04Z","timestamp":1760173084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/4\/857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,15]]},"references-count":55,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,2]]}},"alternative-id":["molecules25040857"],"URL":"https:\/\/doi.org\/10.3390\/molecules25040857","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,15]]}}}